We are live on ! Find out more
XBIO icon

Xenetic Biosciences
XBIO

10 hedge funds and large institutions have $615K invested in Xenetic Biosciences in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

583% more capital invested

Capital invested by funds: $90.1K → $615K (+$525K)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

25% more funds holding

Funds holding: 8 → 10 (+2)

1.88% more ownership

Funds ownership: 1.57% → 3.45% (+1.9%)

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$134K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$48.1K
3
TSS
Two Sigma Securities
New York
+$38.7K
4
VF
Virtu Financial
New York
+$23.7K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$16K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$9K
2
Osaic Holdings
Osaic Holdings
Arizona
-$3K

XBIO Hedge Fund Activity: Q4 2020 in Review

10 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q4 2020, worth a combined $615K — up 583% from $90.1K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new XBIO positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $134K. The largest seller was UBS Group, exiting entirely with an estimated $9K sold.

  • 10 institutional investors held Xenetic Biosciences (XBIO) as of Q4 2020, up from 8 in Q3 2020.
  • Funds reported $615K of Xenetic Biosciences stock for Q4 2020, up 583% quarter-over-quarter.
  • 4 funds opened new Xenetic Biosciences positions in Q4 2020 and 2 closed out, a net change of +2 holders.
  • The largest Xenetic Biosciences buyer in Q4 2020 was Renaissance Technologies, an estimated $134K added.
  • The largest Xenetic Biosciences seller in Q4 2020 was UBS Group, an estimated $9K sold.

Based on aggregated 13F filings for Q4 2020.